PuraPly®

About Organogenesis

Organogenesis is a commercial-stage regenerative medicine company focused on delivering innovative tissue repair solutions. It has a long-standing legacy as an early MIT spin-off and holds some of the first FDA approvals for living, human-cell-based products. The company's mission is to elevate the standard of care through a portfolio of advanced wound care and surgical biologics, supported by comprehensive patient and provider programs. Its strategic direction includes expanding manufacturing capacity, as evidenced by its new Rhode Island facility, to support future growth.

Therapeutic Areas